Cencora (COR) return on equity (ROE)

Return on equity · fiscal 2025
103.1%

Cencora (COR) earned a return on equity of 103.1% in fiscal 2025 (the year ended September 30, 2025). That is 130.6 percentage points lower than the 233.6% of fiscal 2024. Figures as of 17 Nov 2026, 19:27 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
103.1%
Change on fiscal 2024
−130.6 pts
Highest on record
689.5%fiscal 2021
Lowest on record
-22.4%fiscal 2015
Fiscal years on record
172007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Cencora return on equity (ROE), in more detail

Across the 17 fiscal years on record (2007–2025), the highest was 689.5% in fiscal 2021 and the lowest -22.4% in fiscal 2015. The fiscal 2025 figure is higher than in 81% of the 16 earlier fiscal years on record, whose median is 23.1%.

History · 17 fiscal years

Return on equity by fiscal year

Cencora return on equity (ROE), year by year

Cencora (COR) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
2025103.1% 130.6 pts down
2024233.6% 100.7 pts down
2023334.3%—
2021689.5%—
201929.7% 26.8 pts down
201856.5% 38.9 pts up
201717.7% 49.4 pts down
201667.1% 89.5 pts up
2015-22.4% 36.5 pts down
201414.1% 4.7 pts down
201318.8% 10.5 pts down
201229.3% 4.6 pts up
201124.6% 3.1 pts up
201021.6% 3.0 pts up
200918.5% 9.3 pts up
20089.2% 5.9 pts down
200715.1%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of Cencora and comparable companies
CompanyReturn on equityFiscal year
Takeda Pharmaceutical TAK-2.1%2026
Cencora COR103.1%2025
Boston Scientific BSX12.0%2025
Cardinal Health CAH34.1%2021
argenx ARGX17.6%2025
Edwards Lifesciences EW10.4%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on COR

Cencora, figure by figure

Cencora (COR) overview: price, valuation and scorecardAll health care companies by market value

Cencora return on equity (ROE): questions and answers

What is Cencora's return on equity?

Cencora (COR) earned a return on equity of 103.1% in fiscal 2025 (the year ended September 30, 2025). That is 130.6 percentage points lower than the 233.6% of fiscal 2024.

Is Cencora's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in 81% of the 16 earlier fiscal years on record, whose median is 23.1%.

What are the highest and lowest return on equity figures on record for Cencora?

Across the 17 fiscal years on record (2007–2025), the highest was 689.5% in fiscal 2021 and the lowest -22.4% in fiscal 2015.

How is Cencora's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Cencora (COR) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/COR/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.